Elisabeth Ralfkiaer Selected Research

Elisabeth Ralfkiaer Research Topics

Disease

11	Lymphoma (Lymphomas) 04/2016 - 09/2003
8	Neoplasms (Cancer) 07/2017 - 08/2002
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2016 - 08/2003
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2013 - 11/2006
5	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2015 - 06/2009
3	B-Cell Lymphoma (Lymphoma, B Cell) 07/2014 - 11/2006
3	Pathologic Complete Response 05/2014 - 09/2012
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2012 - 05/2009
3	Inflammation (Inflammations) 11/2011 - 08/2009
2	T-Cell Lymphoma (Lymphoma, T Cell) 12/2015 - 05/2009
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2015 - 09/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2015 - 07/2014
2	Primary Myelofibrosis (Myelosclerosis) 03/2012 - 12/2003
1	Multiple Myeloma 01/2019
1	Eye Neoplasms (Eye Cancer) 12/2017
1	Starvation 07/2016
1	Infertility (Sterility) 11/2012
1	Leukemia 11/2012
1	Skin Diseases (Skin Disease) 11/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2011
1	Dermatitis 11/2011
1	Mycosis Fungoides 10/2010
1	Infections 07/2010
1	Necrosis 08/2009
1	Disease Progression 07/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2008
1	Melanoma (Melanoma, Malignant) 03/2004
1	Leukocytosis (Pleocytosis) 12/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2003
1	Dizziness (Lightheadedness) 12/2003
1	Subdural Hematoma (Subdural Hemorrhage) 12/2003
1	Thrombocytosis (Thrombocythemia) 12/2003

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 12/2017 - 05/2014
4	Proteins (Proteins, Gene)FDA Link 12/2015 - 09/2003
3	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2016 - 05/2014
2	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 08/2002
2	Biomarkers (Surrogate Marker)IBA 07/2017 - 07/2009
2	CytokinesIBA 07/2016 - 08/2009
2	Anaplastic Lymphoma KinaseIBA 12/2015 - 09/2012
2	MicroRNAs (MicroRNA)IBA 04/2014 - 11/2011
2	EpitopesIBA 03/2012 - 03/2004
1	Thalidomide (Thalomid)FDA Link 01/2019
1	pomalidomideIBA 01/2019
1	Immunomodulating AgentsIBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	Cell-Free Nucleic AcidsIBA 07/2017
1	Interleukin-2 (IL2)IBA 07/2016
1	Lymphotoxin-alpha (Lymphotoxin)IBA 06/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2014
1	ibritumomab tiuxetan (Zevalin)FDA Link 05/2014
1	Prednisone (Sone)FDA LinkGeneric 05/2014
1	Etoposide (VP 16)FDA LinkGeneric 05/2014
1	Vincristine (Oncovin)FDA LinkGeneric 05/2014
1	Melphalan (Alkeran)FDA LinkGeneric 05/2014
1	A-Form DNA (A-DNA)IBA 12/2013
1	imidazole mustard (BIC)IBA 06/2013
1	Interleukin-17 (Interleukin 17)IBA 06/2011
1	Vorinostat FDA Link 12/2010
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2010
1	IronIBA 07/2010
1	FerrichromeIBA 07/2010
1	SiderophoresIBA 07/2010
1	Lipocalin-2IBA 07/2010
1	factor AIBA 08/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009
1	Phosphotransferases (Kinase)IBA 06/2009
1	NF-kappa B (NF-kB)IBA 06/2009
1	Histone Deacetylase 1IBA 05/2009
1	Histone Deacetylase InhibitorsIBA 05/2009
1	Histones (Histone)IBA 05/2009
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2009
1	Reduced Folate Carrier ProteinIBA 01/2008
1	Messenger RNA (mRNA)IBA 11/2006
1	MetallothioneinIBA 11/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2004
1	SurvivinIBA 03/2004
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2004
1	Peptides (Polypeptides)IBA 03/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2003
1	Imatinib Mesylate (Gleevec)FDA Link 12/2003
1	fas Receptor (CD95 Antigen)IBA 09/2003
1	AntigensIBA 09/2003

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 12/2017 - 08/2003
7	Stem Cell Transplantation 11/2016 - 08/2003
4	Therapeutics 11/2016 - 05/2009
4	Radiotherapy 04/2016 - 10/2011
3	Transplantation 11/2012 - 12/2010
1	Combination Drug Therapy (Combination Chemotherapy) 04/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2012
1	Replantation 11/2012
1	Aftercare (After-Treatment) 01/2008
1	Induction Chemotherapy 08/2003